The journey of Schwann cells from their origin in the neural crest to their ensheathment and myelination of peripheral nerves is a remarkable one. Their apparent static function in enabling saltatory conduction of mature nerve is not only vital for long-term health of peripheral nerve but also belies an innate capacity of terminally differentiated Schwann cells to radically alter their differentiation status in the face of nerve injury. The transition from migrating neural crest cells to nerve ensheathment, and then myelination of large diameter axons has been characterized extensively and several of the transcriptional networks have been identified. However, transcription factors must also modify chromatin structure during Schwann cell maturation and this review will focus on chromatin modification machinery that is involved in promoting the transition to, and maintenance of, myelinating Schwann cells. In addition, Schwann cells are known to play important regenerative roles after peripheral nerve injury, and information on epigenomic reprogramming of the Schwann cell genome has emerged. Characterization of epigenomic requirements for myelin maintenance and Schwann cell responses to injury will be vital in understanding how the various Schwann cell functions can be optimized to maintain and repair peripheral nerve function.
Arthur-FarrajPJLatoucheMWiltonDKQuintesSChabrolEBanerjeeA, and others. 2012. c-Jun reprograms Schwann cells of injured nerves to generate a repair cell essential for regeneration. Neuron75(4):633–47.
2.
Arthur-FarrajPJMorganCCAdamowiczMGomez-SanchezJAFazalSVBeucherA, and others. 2017. Changes in the coding and non-coding transcriptome and DNA methylome that define the Schwann cell repair phenotype after nerve injury. Cell Rep20(11):2719–34.
3.
AtanasoskiSSchererSSSirkowskiELeoneDGarrattANBirchmeierC, and others. 2006. ErbB2 signaling in Schwann cells is mostly dispensable for maintenance of myelinated peripheral nerves and proliferation of adult Schwann cells after injury. J Neurosci26(7):2124–31.
4.
BalohRHStricklandARyuELeNFahrnerTYangM, and others. 2009. Congenital hypomyelinating neuropathy with lethal conduction failure in mice carrying the Egr2 I268N mutation. J Neurosci29(8):2312–21.
5.
BenitoCDavisCMGomez-SanchezJATurmaineMMeijerDPoliV, and others. 2017. STAT3 controls the long-term survival and phenotype of repair Schwann cells during nerve regeneration.J Neurosci37(16):4255–69.
6.
BlackledgeNPRoseNRKloseRJ. 2015. Targeting polycomb systems to regulate gene expression: modifications to a complex story. Nat Rev Mol Cell Biol16(11):643–9.
7.
BremerMFröbFKichkoTReehPTammERSuterU, and others. 2011. Sox10 is required for Schwann-cell homeostasis and myelin maintenance in the adult peripheral nerve. Glia59(7):1022–32.
8.
BritschSGoerichDERiethmacherDPeiranoRIRossnerMNaveKA, and others. 2001. The transcription factor Sox10 is a key regulator of peripheral glial development. Genes Dev15(1):66–78.
9.
Brosius LutzABarresBA. 2014. Contrasting the glial response to axon injury in the central and peripheral nervous systems. Dev Cell28(1):7–17.
10.
Brosius LutzAChungWSSloanSACarsonGAZhouLLovelettE, and others. 2017. Schwann cells use TAM receptor-mediated phagocytosis in addition to autophagy to clear myelin in a mouse model of nerve injury. Proc Natl Acad Sci U S A114(38):E8072–80.
11.
BrüggerVDumanMBochudMMüngerEHellerMRuffS, and others. 2017. Delaying histone deacetylase response to injury accelerates conversion into repair Schwann cells and nerve regeneration. Nat Commun8:14272.
12.
BrüggerVEnglerSPereiraJARuffSHornMWelzlH, and others. 2015. HDAC1/2-dependent P0 expression maintains paranodal and nodal integrity independently of myelin stability through interactions with neurofascins. PLoS Biol13(9):e1002258.
13.
CaloEWysockaJ.2013. Modification of enhancer chromatin: what, how, and why?Mol Cell49(5):825–37.
14.
ChenYWangHYoonSOXuXHottigerMOSvarenJ, and others. 2011. HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination. Nat Neurosci14(4):437–41.
15.
ClementsMPByrneECamarillo GuerreroLFCattinALZakkaLAshrafA, and others. 2017. The wound microenvironment reprograms Schwann cells to invasive mesenchymal-like cells to drive peripheral nerve regeneration. Neuron96(1):98–114.e7.
16.
ClevenAHSannaaGABriaire-de BruijnIIngramDRvan de RijnMRubinBP, and others. 2016. Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival. Mod Pathol29(6):582–90.
17.
De RaedtTBeertEPasmantELuscanABremsHOrtonneN, and others. 2014. PRC2 loss amplifies Ras-driven transcription and confers sensitivity to BRD4-based therapies. Nature514(7521):247–51.
18.
DeckerLDesmarquet-Trin-DinhCTaillebourgEGhislainJVallatJMCharnayP.2006. Peripheral myelin maintenance is a dynamic process requiring constant Krox20 expression. J Neurosci26(38):9771–9.
19.
DengYWuLMNBaiSZhaoCWangHWangJ, and others. 2017. A reciprocal regulatory loop between TAZ/YAP and G-protein Gαs regulates Schwann cell proliferation and myelination. Nat Commun8:15161.
20.
DesmazieresADeckerLVallatJMCharnayPGilardi-HebenstreitP.2008. Disruption of Krox20-Nab interaction in the mouse leads to peripheral neuropathy with biphasic evolution. J Neurosci28(23):5891–900.
21.
DongZSinananAParkinsonDParmantierEMirskyRJessenKR. 1999. Schwann cell development in embryonic mouse nerves. J Neurosci Res56(4):334–48.
22.
FinzschMSchreinerSKichkoTReehPTammEBöslM, and others. 2010. Sox10 is required for Schwann cell identity and progression beyond the immature Schwann cell stage. J Cell Biol189(4):701–12.
23.
GhislainJCharnayP.2006. Control of myelination in Schwann cells: a Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep7(1):52–8.
24.
GhislainJDesmarquet-Trin-DinhCJaegleMMeijerDCharnayPFrainM.2002. Characterisation of cis-acting sequences reveals a biphasic, axon-dependent regulation of Krox20 during Schwann cell development. Development129(1):155–66.
25.
Gomez-SanchezJACartyLIruarrizaga-LejarretaMPalomo-IrigoyenMVarela-ReyMGriffithM, and others. 2015. Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves. J Cell Biol210(1):153–68.
26.
Gomez-SanchezJAGomis-ColomaCMorenilla-PalaoCPeiroGSerraESerranoM, and others. 2013. Epigenetic induction of the Ink4a/Arf locus prevents Schwann cell overproliferation during nerve regeneration and after tumorigenic challenge. Brain136(Pt 7):2262–78.
27.
Gomez-SanchezJAPilchKSvan der LansMFazalSVBenitoCWagstaffLJ, and others. 2017. After nerve injury, lineage tracing shows that myelin and Remak Schwann cells elongate extensively and branch to form repair Schwann cells, which shorten radically on remyelination. J Neurosci37(37):9086–99.
28.
GopinathCLawWDRodríguez-MolinaJFPrasadABSongLCrawfordGE, and others. 2016. Stringent comparative sequence analysis reveals SOX10 as a putative inhibitor of glial cell differentiation. BMC Genomics17(1):887.
29.
GroveMKimHSanterreMKrupkaAJHanSBZhaiJ, and others. 2017. YAP/TAZ initiate and maintain Schwann cell myelination. Elife6.
30.
HeXYuYAwatramaniRLuQR. 2011. Unwrapping myelination by microRNAs. Neuroscientist18:45–55.
31.
HeYKimJYDupreeJTewariAMelendez-VasquezCSvarenJ, and others. 2010. Yy1 as a molecular link between neuregulin and transcriptional modulation of peripheral myelination. Nat Neurosci13(12):1472–80.
32.
HungHAKohnkenRSvarenJ.2012. The nucleosome remodeling and deacetylase chromatin remodeling (NuRD) complex is required for peripheral nerve myelination. J Neurosci32(5):1517–27.
33.
HungHASunGKelesSSvarenJ.2015. Dynamic regulation of Schwann cell enhancers after peripheral nerve injury. J Biol Chem290(11):6937–50.
34.
Isaacman-BeckJSchneiderVFranzini-ArmstrongCGranatoM.2015. The lh3 glycosyltransferase directs target-selective peripheral nerve regeneration. Neuron88(4):691–703.
35.
JacobC. 2017. Chromatin-remodeling enzymes in control of Schwann cell development, maintenance and plasticity. Curr Opin Neurobiol47:24–30.
36.
JacobCChristenCNPereiraJASomandinCBaggioliniALötscherP, and others. 2011. HDAC1 and HDAC2 control the transcriptional program of myelination and the survival of Schwann cells. Nat Neurosci14(4):429–36.
37.
JacobCLötscherPEnglerSBaggioliniAVarum TavaresSBrüggerV, and others. 2014. HDAC1 and HDAC2 control the specification of neural crest cells into peripheral glia. J Neurosci34(17):6112–22.
38.
JagalurNBGhazviniMMandemakersWDriegenSMaasAJonesEA, and others. 2011. Functional dissection of the oct6 Schwann cell enhancer reveals an essential role for dimeric sox10 binding. J Neurosci31(23):8585–94.
39.
JessenKRBrennanAMorganLMirskyRKentAHashimotoY, and others. 1994. The Schwann cell precursor and its fate: a study of cell death and differentiation during gliogenesis in rat embryonic nerves. Neuron12(3):509–27.
40.
JessenKRMirskyR.2016. The repair Schwann cell and its function in regenerating nerves. J Physiol594(13):3521–31.
41.
JessenKRMirskyRArthur-FarrajP.2015. The role of cell plasticity in tissue repair: adaptive cellular reprogramming. Dev Cell34(6):613–20.
42.
JonesEABrewerMHSrinivasanRKruegerCSunGCharneyKN, and others. 2012. Distal enhancers upstream of the Charcot-Marie-Tooth type 1A disease gene PMP22. Hum Mol Genet21(7):1581–91.
43.
KageyMHNewmanJJBilodeauSZhanYOrlandoDAvan BerkumNL, and others. 2010. Mediator and cohesin connect gene expression and chromatin architecture. Nature467(7314):430–5.
44.
KaoSCWuHXieJChangCPRanishJAGraefIA, and others. 2009. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science323(5914):651–4.
45.
KipanyulaMJWoodhooARahmanMPayneDJessenKRMirskyR.2013. Calcineurin-nuclear factor of activated T cells regulation of Krox-20 expression in Schwann cells requires elevation of intracellular cyclic AMP. J Neurosci Res91(1):105–15.
46.
KuhlbrodtKHerbarthBSockEHermans-BorgmeyerIWegnerM.1998. Sox10, a novel transcriptional modulator in glial cells. J Neurosci18(1):237–50.
47.
Le DouarinNMDupinE.2003. Multipotentiality of the neural crest. Curr Opin Genet Dev13(5):529–36.
48.
LeNNagarajanRWangJYArakiTSchmidtREMilbrandtJ.2005a. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci U S A102(7):2596–601.
49.
LeNNagarajanRWangJYSvarenJLaPashCArakiT, and others. 2005b. Nab proteins are essential for peripheral nervous system myelination. Nat Neurosci8(7):932–40.
50.
LeeWTeckieSWiesnerTRanLPrieto GranadaCNLinM, and others. 2014. PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors. Nat Genet46(11):1227-32.
51.
LimpertASBaiSNarayanMWuJYoonSOCarterBD, and others. 2013. NF-κB forms a complex with the chromatin remodeler BRG1 to regulate Schwann cell differentiation. J Neurosci33(6):2388-97.
52.
LinHPOksuzIHurleyEWrabetzLAwatramaniR.2015. Microprocessor complex subunit DiGeorge syndrome critical region gene 8 (Dgcr8) is required for Schwann cell myelination and myelin maintenance. J Biol Chem290(40):24294–307.
53.
Lopez-AnidoCPoitelonYGopinathCMoranJJMaKHLawWD, and others. 2016. Tead1 regulates the expression of peripheral myelin protein 22 during Schwann cell development. Hum Mol Genet25(14):3055–69.
54.
Lopez-AnidoCSunGKoenningMSrinivasanRHungHAEmeryB, and others. 2015. Differential Sox10 genomic occupancy in myelinating glia. Glia63:1897–914.
55.
MaKHHungHASrinivasanRXieHOrkinSHSvarenJ.2015. Regulation of peripheral nerve myelin maintenance by gene repression through polycomb repressive complex 2. J Neurosci35(22):8640–52.
56.
MaKHHungHASvarenJ.2016. Epigenomic regulation of Schwann cell reprogramming in peripheral nerve injury. J Neurosci36(35):9135–47.
57.
MagerGMWardRMSrinivasanRJangSWWrabetzLSvarenJ.2008. Active gene repression by the EGR2/NAB complex during peripheral nerve myelination. J Biol Chem283:18187–97.
58.
MaratheHGMehtaGZhangXDatarIMehrotraAYeungKC, and others. 2013. SWI/SNF enzymes promote SOX10- mediated activation of myelin gene expression. PLoS One8(7):e69037.
MoghaABeneshAEPatraCEngelFBSchönebergTLiebscherI, and others. 2013. Gpr126 functions in Schwann cells to control differentiation and myelination via G-protein activation. J Neurosci33(46):17976–85.
61.
NagarajanRLeNMahoneyHArakiTMilbrandtJ.2002. Deciphering peripheral nerve myelination by using Schwann cell expression profiling. Proc Natl Acad Sci U S A99(13):8998–9003.
62.
NiemiJPDeFrancesco-LisowitzARoldán-HernándezLLindborgJAMandellDZigmondRE. 2013. A critical role for macrophages near axotomized neuronal cell bodies in stimulating nerve regeneration. J Neurosci33(41):16236–48.
PoitelonYLopez-AnidoCCatignasKBertiCPalmisanoMWilliamsonC, and others. 2016. YAP and TAZ control peripheral myelination and the expression of laminin receptors in Schwann cells. Nat Neurosci19(7):879–87.
65.
QuintesSBrinkmannBGEbertMFröbFKunglTArltFA, and others. 2016. Zeb2 is essential for Schwann cell differentiation, myelination and nerve repair. Nat Neurosci19(8):1050–9.
66.
ReiprichSKrieschJSchreinerSWegnerM.2010. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J Neurochem112(3):744–54.
67.
SevetsonBSvarenJMilbrandtJ.2000. A novel activation function for NAB proteins in EGR-dependent transcription of the luteinizing hormone beta gene. J Biol Chem275(13):9749–57.
68.
SimonJALangeCA. 2008. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res647(1-2):21–9.
69.
SrinivasanRMagerGMWardRMMayerJSvarenJ.2006. NAB2 represses transcription by interacting with the CHD4 subunit of the NuRD complex. J Biol Chem281:15129–37.
70.
SrinivasanRSunGKelesSJonesEAJangSWKruegerC, and others. 2012. Genome-wide analysis of EGR2/SOX10 binding in myelinating peripheral nerve. Nucleic Acids Res40:6449–60.
71.
StassartRMFledrichRVelanacVBrinkmannBGSchwabMHMeijerD, and others. 2013. A role for Schwann cell-derived neuregulin-1 in remyelination. Nat Neurosci16(1):48–54.
72.
StoltCCWegnerM.2015. Schwann cells and their transcriptional network: evolution of key regulators of peripheral myelination. Brain Res1641(pt A):101–10.
73.
SvarenJ. 2014. MicroRNA and transcriptional crosstalk in myelinating glia. Neurochem Int77:50–7.
74.
TaveggiaCZanazziGPetrylakAYanoHRosenbluthJEinheberS, and others. 2005. Neuregulin-1 type III determines the ensheathment fate of axons. Neuron47(5):681–94.
75.
TopilkoPSchneider-MaunourySLeviGBaron-Van EvercoorenAChennoufiABSeitanidouT, and others. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature371:796–9.
76.
VaramballySDhanasekaranSMZhouMBarretteTRKumar-SinhaCSandaMG, and others. 2002. The polycomb group protein EZH2 is involved in progression of prostate cancer. Nature419(6907):624–9.
77.
Varela-ReyMIruarrizaga-LejarretaMLozanoJJAransayAMFernandezAFLavinJL, and others. 2014. S-adenosylmethionine levels regulate the Schwann cell DNA methylome. Neuron81(5):1024–39.
78.
VoglMRReiprichSKüspertMKosianTSchreweHNaveKA, and others. 2013. Sox10 cooperates with the mediator subunit 12 during terminal differentiation of myelinating glia. J Neurosci33(15):6679–90.
79.
WangZZangCCuiKSchonesDEBarskiAPengW, and others. 2009. Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell138(5):1019–31.
80.
WarnerLEManciasPButlerIJMcDonaldCMKeppenLKoobKG, and others. 1998. Mutations in the early growth response 2 (EGR2) gene are associated with hereditary myelinopathies. Nat Genet18(4):382–4.
81.
WeiderMKüspertMBischofMVoglMRHornigJLoyK, and others. 2012. Chromatin-remodeling factor Brg1 is required for Schwann cell differentiation and myelination. Dev Cell23(1):193–201.
82.
WoodhooAAlonsoMBDroggitiATurmaineMD’AntonioMParkinsonDB, and others. 2009. Notch controls embryonic Schwann cell differentiation, postnatal myelination and adult plasticity. Nat Neurosci12(7):839–47.
83.
WuLMWangJConidiAZhaoCWangHFordZ, and others. 2016. Zeb2 recruits HDAC-NuRD to inhibit Notch and controls Schwann cell differentiation and remyelination. Nat Neurosci19(8):1060–72.
